Sonova Holding AG (SONVF)
- Previous Close
0.00 - Open
265.00 - Bid 293.90 x 2200
- Ask 320.26 x 2900
- Day's Range
265.00 - 265.00 - 52 Week Range
260.56 - 385.17 - Volume
1 - Avg. Volume
78 - Market Cap (intraday)
19.009B - Beta (5Y Monthly) 1.03
- PE Ratio (TTM)
27.71 - EPS (TTM)
11.51 - Earnings Date May 9, 2025
- Forward Dividend & Yield 4.83 (1.51%)
- Ex-Dividend Date Jun 13, 2024
- 1y Target Est
--
Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved in the design, development, manufacture, distribution, and service of hearing implants and related products under the Advanced Bionics brand. The company sells its products through independent distributors; and provides hearing care services through a network of stores and clinics. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. The company was founded in 1947 and is headquartered in Stäfa, Switzerland.
www.sonova.comRecent News: SONVF
View MorePerformance Overview: SONVF
Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SONVF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SONVF
View MoreValuation Measures
Market Cap
18.13B
Enterprise Value
18.10B
Trailing P/E
25.20
Forward P/E
19.61
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.84
Price/Book (mrq)
6.20
Enterprise Value/Revenue
4.01
Enterprise Value/EBITDA
16.68
Financial Highlights
Profitability and Income Statement
Profit Margin
15.23%
Return on Assets (ttm)
7.85%
Return on Equity (ttm)
25.75%
Revenue (ttm)
3.71B
Net Income Avi to Common (ttm)
564.7M
Diluted EPS (ttm)
11.51
Balance Sheet and Cash Flow
Total Cash (mrq)
278.9M
Total Debt/Equity (mrq)
72.11%
Levered Free Cash Flow (ttm)
607.84M